Editas Medicine, Inc.
EDIT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $186 | $96 | $105 |
| - Cash | $166 | $139 | $139 | $132 |
| + Debt | $14 | $78 | $31 | $35 |
| Enterprise Value | – | $125 | -$11 | $8 |
| Revenue | $8 | $4 | $5 | $31 |
| % Growth | 110.8% | -23.2% | -84.8% | – |
| Gross Profit | $8 | $4 | $5 | $31 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$22 | -$49 | -$72 | -$33 |
| % Margin | -291.6% | -1,380.1% | -1,544.8% | -107.8% |
| Net Income | -$25 | -$53 | -$76 | -$45 |
| % Margin | -333% | -1,487.8% | -1,633.5% | -148.3% |
| EPS Diluted | -0.28 | -0.63 | -0.92 | -0.55 |
| % Growth | 55.6% | 31.5% | -67.3% | – |
| Operating Cash Flow | -$31 | -$50 | -$48 | -$51 |
| Capital Expenditures | -$0 | $0 | -$0 | -$1 |
| Free Cash Flow | -$31 | -$50 | -$48 | -$51 |